Oral Communication on Cancer and Thrombosis

Thursday 23 October

Abstract titles & Authors

Moderators: Nick van Es, Patricia Verger Martin

09.00
09.15

OC05-OP01 – WHICH FACTORS ARE ASSOCIATED BLEEDING AND THROMBOSIS DURING THE LAST PHASE OF LIFE IN CANCER PATIENTS? – Jamilla Goedegebuur, Leiden University Medical Center

09.15
09.30

OC05-OP02 – OVARIAN CANCER-RELATED BIOFLUIDS FROM PATIENTS AND CELL LINES INDUCE NEUTROPHIL REPROGRAMMING TOWARDS A PRO-TUMORAL PHENOTYPE – Sarai Tomás Pérez, Fundación de Investigación del Hospital General Universitario de Valencia

09.30
09.45

OC05-OP03 – THE ROLE OF NEUTROPHILS IN CHEMOTHERAPY RESISTANCE AND HYPERCOAGULABILITY IN 3D CELL CULTURES OF MUSCLE-INVASIVE BLADDER CANCER – Raquel Herranz, The Health Research Institute Hospital La Fe (IIS La Fe)

09.45
10.00

OC05-OP04 – LIQUID BIOPSY FOR PEDIATRIC TUMORS: NEUTROPHIL EXTRACELLULAR TRAPS (NETS) AS NOVEL MINIMALLY INVASIVE BIOMARKERS – Patricia Verger Martin, Health Research Institute Hospital La Fe

10.00
10.15

OC05-OP05 – PLASMA MIR-145 AND THE RISK OF FUTURE CANCER-ASSOCIATED VENOUS THROMBOEMBOLISM – Christopher Antoun, UiT The Arctic University of Norway

10.15
10.30

OC05-OP06 – BLADDER CANCER CELLS INDUCE A PROCOAGULANT STATE THROUGH TISSUE FACTOR AND NETS DRIVE THEIR MALIGNANT TRAITS – Raquel Herranz, The Health Research Institute Hospital La Fe (IIS La Fe)